CUSIP: M53071136
What is CUSIP M53071136?
CUSIP M53071136 identifies ICCM - IceCure Medical Ltd. - Ordinary Shares, no par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP M53071136:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Haixiang Li | 46% | $33,083,644 | 25,846,597 | Epoch Partner Investments Limited | 23 Dec 2024 |
As of 31 Dec 2025, 19 institutional investors reported holding 524,803 shares of IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM). This represents 0.93% of the company’s total 56,557,105 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 524,803 | $318,670 | +$120,277 | $0.61 | 19 |
| 2025 Q3 | 293,952 | $297,190 | +$44,653 | $1.02 | 16 |
| 2025 Q2 | 249,665 | $247,019 | +$111,871 | $1.00 | 17 |
| 2025 Q1 | 129,931 | $152,798 | -$25,681 | $1.18 | 13 |
| 2024 Q4 | 153,141 | $167,705 | +$11,943 | $1.10 | 12 |
| 2024 Q3 | 194,284 | $117,866 | -$136,022 | $0.61 | 14 |
| 2024 Q2 | 361,028 | $267,533 | +$176,987 | $0.74 | 14 |
| 2024 Q1 | 100,498 | $120,094 | -$179,494 | $1.20 | 12 |
| 2023 Q4 | 268,137 | $290,607 | +$75,177 | $1.07 | 15 |
| 2023 Q3 | 232,538 | $127,536 | +$2,901 | $0.54 | 11 |
| 2023 Q2 | 155,395 | $180,324 | +$93,065 | $1.16 | 10 |
| 2023 Q1 | 75,937 | $87,537 | -$90,529 | $1.15 | 6 |
| 2022 Q4 | 158,151 | $244,966 | +$143,970 | $1.55 | 9 |
| 2022 Q3 | 65,291 | $84,309 | -$66,120 | $1.29 | 6 |
| 2022 Q2 | 63,859 | $174,427 | +$42,045 | $1.70 | 8 |
| 2022 Q1 | 71,148 | $171,607 | -$2,106,694 | $2.43 | 9 |
| 2021 Q4 | 764,988 | $2,313,000 | +$1,159,901 | $3.02 | 12 |
| 2021 Q3 | 382,011 | $3,338,000 | +$3,338,000 | $8.83 | 7 |